Metastatic basal cell carcinoma presenting as unilateral lymphedema

Mary M. Christian, Christine M. Murphy, Richard Wagner

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.

Original languageEnglish (US)
Pages (from-to)1151-1153
Number of pages3
JournalDermatologic Surgery
Volume24
Issue number10
StatePublished - Oct 1998

Fingerprint

Lymphedema
Basal Cell Carcinoma
Neoplasm Metastasis
Recurrence
Muscle Weakness
Anemia
Lymph Nodes
Radiation
Bone and Bones
Pain
Survival

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Metastatic basal cell carcinoma presenting as unilateral lymphedema. / Christian, Mary M.; Murphy, Christine M.; Wagner, Richard.

In: Dermatologic Surgery, Vol. 24, No. 10, 10.1998, p. 1151-1153.

Research output: Contribution to journalArticle

Christian, MM, Murphy, CM & Wagner, R 1998, 'Metastatic basal cell carcinoma presenting as unilateral lymphedema', Dermatologic Surgery, vol. 24, no. 10, pp. 1151-1153.
Christian, Mary M. ; Murphy, Christine M. ; Wagner, Richard. / Metastatic basal cell carcinoma presenting as unilateral lymphedema. In: Dermatologic Surgery. 1998 ; Vol. 24, No. 10. pp. 1151-1153.
@article{c037d0014da54754b3bb319c14a1860e,
title = "Metastatic basal cell carcinoma presenting as unilateral lymphedema",
abstract = "BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55{\%} of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.",
author = "Christian, {Mary M.} and Murphy, {Christine M.} and Richard Wagner",
year = "1998",
month = "10",
language = "English (US)",
volume = "24",
pages = "1151--1153",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Metastatic basal cell carcinoma presenting as unilateral lymphedema

AU - Christian, Mary M.

AU - Murphy, Christine M.

AU - Wagner, Richard

PY - 1998/10

Y1 - 1998/10

N2 - BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.

AB - BACKGROUND. Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis. OBJECTIVE. Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature. METHODS. Case report with literature review. RESULTS. Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence. CONCLUSION. To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.

UR - http://www.scopus.com/inward/record.url?scp=0031788513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031788513&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 1151

EP - 1153

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 10

ER -